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Abstract
NMB0315 is an outer membrane protein of Neisseria meningitidis serogroup B (NMB) and a potential candidate for a broad-
spectrum vaccine against meningococcal disease. The crystal structure of NMB0315 was solved by single-wavelength
anomalous dispersion (SAD) at a resolution of 2.4 A ˚ and revealed to be a lysostaphin-type peptidase of the M23
metallopeptidase family. The overall structure consists of three well-separated domains and has no similarity to any
previously published structure. However, only the topology of the carboxyl-terminal domain is highly conserved among
members of this family, and this domain is a zinc-dependent catalytic unit. The amino-terminal domain of the structure
blocks the substrate binding pocket in the carboxyl-terminal domain, indicating that the wild-type full-length protein is in
an inactive conformational state. Our studies improve the understanding of the catalytic mechanism of M23
metallopeptidases.
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Introduction
Neisseria meningitidis, a commensal bacterium found in the human
nasopharynx, has caused global health concerns owing to its
potential to cause meningitis and sepsis. Pandemic outbreaks of
meningococcal disease (MD), which have been reported world-
wide, can be devastating, with a mortality rate of approximately
10% in many countries [1,2]. Because of the rapid progress of the
disease after its onset, early prevention seems to be indispensable
in seeking a cure, leading to a global research effort to create a
vaccine. The majority of MD is caused by 6 of the 13 serogroups
of Neisseria meningitidis, as classified according to the polysaccharide
capsule surrounding the bacterium [3,4]. Despite a number of
specific vaccines that have been developed against these
pathogens, frequent antigenic variation hampers the generation
of a broad-spectrum vaccine. The outer membrane proteins
(OMPs) of N. meningitidis, which have been implicated in bacterial
virulence, can effectively induce an immune response and thus are
a good antigen candidate for vaccine design [5]. For such reasons,
a number of OMPs have been identified and studied, including
NMB0315, a putative metallopeptidase.
NMB0315 is an OMP identified in Neisseria meningitidis as
belonging to serogroup B. The development of a universal vaccine
against this group remains a challenge [6]. Although few studies
have been dedicated to the uncharacterized protein NMB0315,
sequence similarities suggest that it is a lysostaphin-type metallo-
peptidase [7,8] belonging to the M23 peptidase family [9].
Proteins in this family are characterized by a conserved active site
containing an HXH motif [8,10], and all are zinc-dependent.
They have been reported to have a hydrolytic specificity for a
glycine-glycine peptide bond [11,12,13]. Over the past few
decades, many members of the M23 metallopeptidase family have
been identified, and fine structure analysis has been performed for
some. Although the proteolytic mechanism of the conserved Zn
2+-
containing active site has been proposed and discussed, the
diversity of the overall structures has resulted in confusion
regarding their functional similarity in different bacteria
[14,15,16]. Moreover, it has been reported that some of the
Zn
2+-dependent peptidases were synthesized as proenzymes and
thus are inactive against the preferred substrates, such as
polyglycine peptides [14,17,18].
In Gram-positive bacteria, such as Bacillus subtilis, lysostaphins
are involved in the degradation of cell wall peptidoglycan during
cell growth and separation [19,20]. However, in Gram-negative
bacteria, the peptidoglycan cell wall is directly crosslinked to each
other, and thus, it lacks the glycine-rich linker targeted by these
peptidases [21]. In Pseudomonas aeruginosa, LasA, which contributes
to the virulence of P. aeruginosa, has been confirmed to be an M23
peptidase and implicated in elastin degradation [22]. Another
Gram-negative bacterial M23 peptidase, the Yersinia pestis NlpD
lipoprotein, has been shown not only to be required in cell division
but also to serve as an essential virulence factor for bubonic and
pneumonic plague development [23]. Moreover, mutant NlpD
appeared to be a superior vaccine candidate that provided
effective immunity, indicating the potential for members of the
M23 peptidase family in Gram-negative bacteria to be used for
disease prevention [23].
A BLAST sequence search showed that certain proteins with at
least 98% sequence identity to NMB0315 were found not only in
different serogroups of N. meningitidis but also in Neisseria gonorrhoeae,
PLoS ONE | www.plosone.org 1 October 2011 | Volume 6 | Issue 10 | e26845the other species of the genus Neisseria that is pathogenic in humans
[24]. Although these two virulent species differ in niche preference
and the nature of the induced disease, their use of the same survival
or pathogenic mechanism based on NMB0315 is intriguing.
Here, we show the crystal structure of NMB0315 at 2.4 A ˚
resolution. A metal-coordinating site in our structure resembles the
previously reported structure of a Zn
2+-containing metalloendo-
peptidase, indicating that NMB0315 is a member of the M23
peptidase family.
Results
Overall structure of NMB0315
The structure of NMB0315 was solved by single-wavelength
anomalous dispersion at 2.4 A ˚ resolution. Two molecules of
NMB0315 were present in one asymmetric unit. In the final
model, molecule A covers residues 57–95, 102–245, 250–262 and
266–420, whereas molecule B covers residues 58–245 and 251–
420. The two molecules in the asymmetric unit have a root-mean-
square deviation (RMSD) value of 0.7 A ˚ for the 349 Ca atoms. We
will refer only to molecule B in the following discussion.
The overall structure consists of three spatially separated
domains (Figure 1): Domain I (residues 58–151), Domain II
(residues 152–265 and 397–420) and Domain III (residues 266–
396). Domain I contains five anti-parallel b-strands (b1-b5) flanked
by two a-helices (a1-a2). Domain II is made up of four a-helices
(a3-a6), six b-strands (b6-b11) and one long C-terminal a-helix
(a7). Domain III is solely formed by ten b-strands (b12-b21)
(Figure 1). Two anti-parallel b-strands (b13 and b14) of Domain
III extend out and interact with a b-strand of Domain I. The b3-
b4 loop of Domain I points into the groove of the central b-strand
region of Domain III.
The active site
The 2Fo-Fc electron density map reveals a metal ion bound in
domain III (Figure 2A). This metal ion is coordinated by three
spatially adjacent residues (His295, Asp299, and His375) and two
water molecules (W142 and W141). Two other histidines, His343
and His373, take part in interactions with the metal ion through
the water molecule W141 (Figure 2A). This organization of the
active site is highly conserved in M23 family members (Figure 2B).
A sequence alignment also reveals that these five residues are
highly conserved among M23 peptidases (Figure 2C). Because all
peptidases of this family that have been found so far are zinc-
dependent, we first searched for zinc in our structure. However, no
signal was detected for a zinc atom in an X-ray fluorescence
spectrum. One possibility is that the Zn
2+ was replaced by another
metal ion such as Ni
2+ during the expression and purification of
the protein.
To test this hypothesis, we treated the NMB0315 protein with
EDTA to chelate bound metal ions and induce reuptake of Zn
2+
into NMB0315 (for details, please see the methods section). The
atomic absorption spectroscopy data clearly show that the mole
ratio of Zn
2+:protein is around 0.7, indicating that Zn
2+ is included
in the NMB0315 protein (Figure 2D). On the other hand, we
purified Maltose binding protein (MBP) fused NMB0315 by MBP
beads (GE healthcare) and Gel-filtration column. We found that
the mole ratio of Zn
2+:MBP-NMB0315 is around 0.6, confirming
that Zn
2+ can bind in the active site of NMB0315 (Figure 2E). To
directly measure the binding affinity of Zn
2+ with NMB0315, we
titrated Zn
2+ into NMB0315 protein pre-treated with EDTA using
isothermal titration calorimetry (ITC). The calculated Kd value is
,18.5 nM (Figure 2F).
Structure comparison of NMB0315 and other M23
metallopeptidases
A structural comparison based on entire structure of NMB0315
using the Dali Server [25] resulted in only one structure that is
similar to NMB0315, a putative lysostaphin-type protein from
Vibrio cholerae (referred to as Vly hereafter) (PDB ID: 2GU1). This
three-domain containing protein belongs to the M23 peptidase
superfamily and has been reported to be in an inhibited
Figure 1. Crystal structure of NMB0315. (A) Overall topology of NMB0315. (B) Cartoon representation of NMB0315. The metal atom is shown as
a red ball. Domains I, II and III are colored in orange, blue and green, respectively.
doi:10.1371/journal.pone.0026845.g001
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PLoS ONE | www.plosone.org 2 October 2011 | Volume 6 | Issue 10 | e26845Figure 2. The catalytic pocket of NMB0315. (A) The metal ion binding site. Nitrogen, oxygen and carbon atoms are colored blue, red and cyan,
respectively. The metal ion and water molecules are shown as red and yellow balls, respectively. The initial experimental electron density map
calculated from the SAD phases is shown contoured at 14s in black. Hydrogen bonds are shown as red dashed lines. (B) The superposition of the
active site of NMB0315 onto LasA. The side chains of conserved residues are shown as sticks, and the main chain is shown as loops. NMB0315 is
colored cyan, with the nitrogen and oxygen atoms of the side chains colored blue and red, respectively. LasA is colored gray. The metal ions of
NMB0315 and LasA in the active sites are represented as red and light pink spheres, respectively. (C) Sequence alignment of NMB0315, Vly and LytM.
Secondary structure elements of NMB0315 are shown as arrows (b-strands). The amino acids highlighted in red and denoted with asterisks are key
residues in the active site that are conserved across the three proteins. (D,E) The atomic absorption spectrum for the different metal elements in the
purified NMB0315 protein solution. (F) ITC measurement of the binding affinity between Zn
2+ and NMB0315.
doi:10.1371/journal.pone.0026845.g002
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NMB0315 and Vly showed that the overall spatial arrangement of
the three domains is distinct. However, the corresponding
individual domains resemble one another (Figure 3A,B). This is
especially true for Domain III, for which the comparison of these
two domains is strikingly similar, with an RMSD value of 1.5A ˚ for
112 Ca atoms (Figure 3C). Moreover, the three-dimensional
structural features of Domain III are shared by many other
proteins. More than 10 structural homologs of Domain III alone
were found by the Dali Server, including the catalytic domain of
LytM from Staphylococcus aureus (PDB ID: 2B13) (Figure 3D) and
LasA from Pseudomonas aeruginosa (PDB ID: 3IT5) (Figure 3E).
LytM is a zinc-dependent lysostaphin-type metallopeptidase
involved in the autolysis mediated by Staphylococcus aureus, which
is required for bacterial cell growth, separation and metabolism
[26]. The structure of the active fragment of LytM has strong
similarities to Domain III of NMB0315, but differences exist. A
notable distinction between the two structures is the b12-b15
segment, which extends far from the b core in NMB0315 but is
shorter in LytM (Figure 3D).
LasA is another M23 metallopeptidase known to be involved in
entry to the host cell and other processes related to Pseudomonas
aeruginosa virulence [22,27,28]. Like LytM, LasA shares a
conserved b-strand region corresponding to the catalytic groove.
Figure 3. Structure comparison of NMB0315 with other M23 metallopeptidases. (A) Comparison of the overall structure of NMB0315 (left)
and Vly (right). Each domain from one protein resembles the corresponding domain in the other; however, the spatial arrangements of the three
domains between the two proteins are different. (B) Stereoview of the superposition of NMB0315 onto Vly (yellow), LytM (magenta) (C), or LasA
(orange) (D).
doi:10.1371/journal.pone.0026845.g003
Crystal Structure of NMB0315
PLoS ONE | www.plosone.org 4 October 2011 | Volume 6 | Issue 10 | e26845However, it differs most in the C-terminus of NMB0315 Domain
III, forming a three stranded b-sheet (Figure 3E) rather than an a-
helix (Figure 3A).
Auto-inhibition state of NMB0315
In our structure, the short b3-b4 loop of Domain I stretches into
the catalytic center of Domain III and forms numerous
interactions (Figure 4A). First, the b4 strand of Domain I forms
an anti-parallel interaction with the b14 strand of Domain III, and
they stabilize each other through several main-chain hydrogen
bonds. Second, Glu132 of Domain I makes a salt bridge with
Arg293 of Domain III. Third, the main-chain atoms of Gly131 of
Domain I make two hydrogen bonds with two residues Tyr325
and Thr296 of Domain III. Fourth, Asp130 of Domain I forms a
hydrogen bond with the carbonyl oxygen atom of Gly324 from
Domain III. Based on these interactions, Domain I of NMB0315 is
capable of tightly associating with Domain III, which blocks the
active site and the substrate binding groove (Figure 4B), suggesting
that full-length NMB0315 is in an auto-inhibited conformational
state. This kind of inhibition seems to be quite different from other
members of M23 metallopeptidase family, including Vly and
LytM. The full-length Vly protein is also in a latent form, and the
inhibition of its active site is achieved by an N-terminal helix from
Domain I (Figure 4C). Wild-type LytM is also inhibited by its long
N-terminal loop (Figure 4D) and strongly activated by the
physiologically unrelated peptidase trypsin [29]. In contrast, the
active site and substrate binding groove of the protein LasA are
wide open and ready for substrate entry (Figure 4E).
Discussion
Our results suggest that NMB0315 is a zinc-dependent peptidase
and belongs to the M23 metallopeptidase family. A metal-
containing active site was observed in our structure, in which one
asparagine and two histidines are involved in the central metal ion
coordination,withtwoadditional histidines flanking one side. Given
that this active site is highly conserved among members of this
family, NMB0315 likely prefers glycine-containing peptides as its
substrates. Remarkably, two water molecules, which were found to
be involved inthe coordination ofthemetalion, bondedinthesame
way as that reported for the crystal structure of LasA [15]. A
catalytic mechanism has been proposed based on the configuration
of the active site of LasA. The incoming substrate peptide may take
thepositionof one watermolecule (correspondingtoW142),withits
peptide carbonyl bond polarized by the metal ion, and the other
water molecule (correspondingto W141) likely functions as a proton
donor,performing a nucleophilic attackon the carbonyl carbon and
causing the hydrolysis of the peptide [15]. In the active site of our
structure, both the residue arrangement and the two water binding
sites resemble that of LasA, suggesting that a similar mechanism of
catalysis may exist for NMB0315.
Interestingly, a short loop from Domain I of NMB0315 is
positioned in the vicinity of the active site, apparently blocking
peptide substrates. This intruding loop is further stabilized by
interactions with several spatially adjacent residues (Figure 4A),
which seemingly renders the peptidase constitutively inactive. This
inhibition strategy differs from that of the other reported structures
of M23 metallopeptidases, such as full-length LytM, which is self-
inhibited by a loop from its N-terminus [14]. In the structure of
Vly, an a-helix from the first domain, instead of a loop, prevents
substrate access to the active site [16]. By contrast, despite the
above differences, all three proteins share the conformational
feature of using a segment of the N-terminus to block the active
site. This evidence suggests that NMB0315, like other lysostaphins,
is synthesized as a proenzyme and needs further processing to
become active [29].
Based on the comparison of NMB0315 and other M23
metallopeptidases in their active form, we propose that the
maturation of NMB0315 requires the amino-terminal domain to
be removed. However, the truncated segment containing only
domain III was very unstable and therefore had a low yield, which
hindered any investigation into its catalytic activity. Further studies
on NMB0315 and other peptidases from this family are expected
to provide a more complete understanding of the inhibition,
activation and hydrolytic mechanism of M23 metallopeptidases.
Figure 4. The auto-inhibition mechanism of NMB0315. (A) The
inhibition loop of Domain I of NMB0315 is stabilized by numerous
interactions with Domain III. The main chains of Domain I and Domain
III are colored orange and green, respectively. The hydrogen bonds are
shown as dashed magenta lines. The substrate binding grooves are
blocked in NMB0315 (B), Vly (C), and LytM (D) but open in LasA (E). The
catalytic domains of these four proteins are shown as surfaces in (B),
(C), (D) and (E), and the inhibiting domains are shown as cartoons. The
metal ions (M
2+) in the active sites of these enzymes are represented as
cyan spheres. A tartrate molecule is colored as magenta in the open
catalytic site of LasA.
doi:10.1371/journal.pone.0026845.g004
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Protein expression and purification
The gene encoding residues 54–420 of NMB0315 protein were
cloned into a modified pET-32a (Novagen) vector, in which the
Trx tag was deleted by cleavage at two NdeI restriction sites and
the thrombin site and the S tag were replaced by a prescission
protease site (Leu-Glu-Val-Leu-Phe-Gln-Gly-Pro) and trans-
formed into E. coli BL21 (DE3) cells. The resultant cells were
then grown in LB medium at 25uC to A600=0.6, induced by
isopropyl-1-thiogalactopyranoside (IPTG) at a final concentration
of 0.2 mM and harvested after overnight incubation.
The cells were lysed in T20N500P0.1 buffer (20 mM Tris-HCl
pH 7.0, 0.1 mM phenylmethylsulfonyl fluoride, 500 mM NaCl)
by lysozyme (0.1 mg/ml) and sonication. After centrifugation at
20,000 g for 60 min, the supernatant was loaded onto a Ni-NTA
column, washed with T20N500P0.1 buffer containing 20 mM
imidazole and eluted with the same buffer to which 500 mM
imidazole had been added. The eluted His6-tagged protein was
digested by prescission protease at 4uC overnight and further
purified by gel filtration on a Superdex G-200 column (GE
Healthcare) in T20N500 buffer.
DNA fragment encoding residues 54–420 of NMB0315 was
cloned into the pET-MBP vector (Novagen) and then transformed
into BL21 codon plus Escherichia coli cells. The overexpressed
protein lysate in T20N400 buffer (20 mM Tris-HCl, pH 7.0 and
400 mM NaCl) was loaded directly onto an MBPTrap HP column
(GE Healthcare). After washing the column with 5 column
volumes of T20N400 buffer, the MBP-tagged protein was eluted
with T20N400 buffer containing 10 mM maltose. The fusion
protein was loaded onto a HighLoad 26/60 Superdex-200 size-
exclusion column (GE Healthcare) and eluted with T20N400 buffer
at a flow rate of 2.0 ml/min. The protein peak was identified by
SDS-PAGE gel and harvested and concentrated by Centricon
(Millipore).
Seleno-methionine (Se-Met) labeled NMB0315 was expressed
by E. coli B834 cells, which are methionine auxotrophs, in minimal
medium under the conditions described above, and the derived
protein was also purified following the protocol above.
Crystallization and data collection
Crystals of either wild-type or Se-Met substituted NMB0315
were grown at 4uC at a protein concentration of 40 mg/ml using
the sitting drop vapor diffusion method and equilibration against a
reservoir solution of 7% PEG20,000, 0.1 M Tris-HCl, pH 8.5 and
2% 1,4-Dioxane. After growing for more than 5 days, the crystals
were frozen in a cryoprotectant consisting of the reservoir solution
supplemented with 25% glycerol.
Both the native dataset for the wild-type crystal and the single
wavelength anomalous dispersion dataset for the Se-Met deriva-
tive were collected at the Shanghai Synchrotron Radiation Facility
(SSRF). The latter was collected at the peak wavelength for Se
atoms. The wild-type crystals of NMB0315 diffracted to 2.40 A ˚ in
the space group C2 with unit cell dimensions of a=195.68 A ˚,
b=75.50 A ˚, c=81.64 A ˚ and b=94.66u. The Se-Met substituted
crystals diffracted to 2.85 A ˚ in the same space group and unit cell
dimensions of a=195.20 A ˚, b=76.63 A ˚, c=81.58 A ˚ and
b=94.78u. Both datasets were processed and scaled with the
HKL2000 software package [30].
Structure determination and refinement
The program HKL2MAP [31] yielded seven of the eight
theoretical Se sites in one asymmetric unit, and the initial SAD
phases were calculated by PHENIX software [32]. The model was
first built automatically by the PHENIX program package and
then manually modeled using the COOT [33] program on the
basis of 2Fo–Fc and Fo–Fc difference Fourier maps. The structure
model was refined using the CNS [34] program. The final
structure had an Rcryst value of 25.5% and an Rfree value of 26.4%.
The Ramachandran plot calculated by PROCHECK [35] showed
that 83.2% of the residues were in their most favored regions;
15.2% of the residues were in additionally allowed regions; 1.7%
of the residues were in generously allowed regions; and no residues
were in disallowed regions. Detailed data collection and
refinement statistics are summarized in Table 1.
Zn
2+ reuptake and atomic absorption spectrum
To chelate metal ions in purified NMB0315, the protein
(100 mM) was incubated with 10 mM EDTA at 4uC overnight.
EDTA was then removed by loading the mixture onto a HiPrep
26/10 desalting column (GE Healthcare) and eluting the protein
with T20N500 buffer. The Zn
2+ reuptake was carried out by adding
Table 1. Data collection and refinement statistics.
Crystal name Wild-type Se-Met-crystal
Space group C2 C2
Unit cell (A ˚) a=195.68, b=71.50,
c=81.64,b=94.66u
a=195.20, b=76.63,
c=81.58, b=94.78u
Wavelength (A ˚) 0.9796 0.9792
Resolution range (A ˚) 50–2.40
(2.49–2.40)
50–2.85
(2.96–2.85)
No. of unique reflections 38,289 25,693
Redundancy 6.0(4.4)
a 3.7(2.8)
a
Rsym (%)
b 6.6(44.9)
a 9.2(36.9)
a
I/s 24.6(2.4)
a 17.0(1.9)
a
Completeness (%) 99.5(50.5)
a 99.2(46.1)
a
FOM --- 0.685
Refinement
Resolution range (A ˚) 37.75,2.41
Rcrystal (%)
c 25.5
Rfree (%)
d 26.4
RMSDbond (A ˚) 0.007
RMSDangle(u)1 . 0
Number of
Protein atoms
Ligand atoms
5,364
2
Solvent atoms 0
Residues in (%)
most favored 494
additional allowed 90
Generously allowed 10
disallowed 0
Average B factor (A ˚2)o f
Protein
Ligand atoms
84.92
73.37
athe highest resolution shell.
bRsym~
X
j SIT{Ij
       
.X
SIT
cRcrystal=
P
hkl Fobs{Fcalc jj
 P
hkl Fobs
dRfree, calculated the same as Rcrystal, but from a test set containing 5% of data
excluded from the refinement calculation.
doi:10.1371/journal.pone.0026845.t001
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5 mM and then incubating the mixture at 4uC overnight. The
residual ZnSO4 was removed by passing the sample through a
HiPrep 26/10 desalting column using T20N500 buffer.
To determine the atomic absorption spectrum, the 0.2 ml
protein solution after Zn
2+ reuptake was supplemented with 2 ml
65% nitric acid and incubated overnight. The sample was then
diluted with double-distilled water and the concentrations of metal
ions were determined by a polarized Zeeman Atomic Absorption
spectrophotometer.
Isothermal titration calorimetry
Measurements were carried out using an ITC-200 microcalo-
rimeter (MicroCal) in T20N400 buffer (20 mM Tris-HCl pH 7.0,
400 mM NaCl) at room temperature. All samples were spun at
15,000 6 g for degassing, and their concentrations were
determined by both Bradford assay and spectrophotometry
(280 nm wavelength). Sample solutions with a concentration of
0.05 mM were put into the sample cell, and the titration solution
in the injection syringe was kept around 1 mM. To measure the
binding constants, 20 consecutive injections of the titration into the
calorimeter cell were collected at 120 intervals while being stirred
at 1,000 rpm. The titration data were analyzed using MicroCal
Origin software (MicroCal).
Protein Data Bank and accession code
Coordinate and structure factor have been deposited in the
Protein Data Bank with accession code 3SLU.
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